Foundation Makes AIDS Drug Deal

Published Online: Wednesday, February 1, 2006

African and Caribbean nations ravaged by the HIV epidemic will be able to obtain low-cost generic versions of 2 key antiretroviral drugs under a deal brokered by former President Bill Clinton's AIDS Foundation.

Under the arrangement, poor countries—including Swaziland, Lesotho, Seychelles, Mauritius, and Madagascar—will get access to generic efavirenz and abacavir at prices that have been estimated at $240 per patient per year.

Aspen Pharmacare and Indian generic drug manufacturers Ranbaxy, Cipla, and Strides Acrolabs will supply efavirenz. Cipla will also supply abacavir.

Latest Articles
Pharmacies are rated as some of the best places to receive top-notch customer service in America.
Often caused by acid reflux, eosinophilic esophagitis is an emerging inflammatory disease that is generally unresponsive to proton pump inhibitor therapy.
Carlos Aquino, founder and president of PharmaDiversion LLC, discusses timing of inspections from the Drug Enforcement Administration.
The FDA has again rejected AMAG Pharmaceuticals’ application for a single-dose version of hydroxyprogesterone caproate injection (Makena) to reduce the risk of preterm birth for at-risk women.
Latest Issues